Ryoki Hara

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

Fabrizio De Benedetti, Marco Gattorno, Jordi Antón et al. · New England Journal of Medicine · 2018 · 473 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study

Yoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka et al. · Lara D. Veeken · 2019 · 122 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +14

Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series

Masaaki Mori, Tomoyuki Imagawa, Ryoki Hara et al. · The Journal of Rheumatology · 2012 · 75 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13

Association of<i>IRF5</i>Polymorphisms with Susceptibility to Macrophage Activation Syndrome in Patients with Juvenile Idiopathic Arthritis

Masakatsu Yanagimachi, Takuya Naruto, Takako Miyamae et al. · The Journal of Rheumatology · 2011 · 65 citations · Full text

Life Sciences, Genetics, Immunology +14

Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis

Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara et al. · British Journal of Clinical Pharmacology · 2010 · 58 citations · Full text

Medicine, Genetics, Pharmacology +14